Medicine
Ceftriaxone 250 mg powder for injection
Ceftriaxone 250 mg powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
The following packages are available: Vials containing ceftriaxone sodium…
Key facts
- Active ingredient (INN)
- Ceftriaxone
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials, 1 vial, 25 vials and 10 more
- Manufacturers
- A-S Medication SolutionsApotexHospiraQilu PharmaceuticalSandozSportpharmHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- The following packages are available: Vials containing ceftriaxone sodium equivalent to 250 mg ceftriaxone Box of 25 (NDC 0143-9859-25) Vials containing ceftriaxone sodium equivalent to 500 mg ceftriaxone Box of 25 (NDC 0143-9858-25) Vials containing ceftriaxone sodium equivalent to 1 gm ceftriaxone Box of 25 (NDC 0143-9857-25) Vials containing ceftriaxone sodium equivalent to 2 gm ceftriaxone…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD04 Ceftriaxone
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2005
- Identifiers
- RxCUI 309092, 1665005, 1665021 +1DailyMed set ID 8351aa37-552d-471d-b293-c564dcb6ec29, de028434-46cf-44f6-8ac6-889c7c6943b3, 4cdf0743-c62b-4969-b9c9-4c6400644f6c +6NDC 0143-9859, 0781-3206, 67184-1005 +5Application ANDA065342, ANDA065169, ANDA203702
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0409-7337-01 | Hospira | 9 May 2005 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0409-7337-20 | Hospira | 19 March 2018 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 60505-6151-1 | Apotex | 30 June 2017 |
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 60505-6151-4 | Apotex | 30 June 2017 |
| 25 vial in 1 box / 1 injection, powder, for solution in 1 vial | 0143-9859-25 | Hikma Pharmaceuticals | 10 January 2008 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 67184-1005-1 | Qilu Pharmaceutical | 29 June 2016 |
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 67184-1005-2 | Qilu Pharmaceutical | 29 June 2016 |
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0781-3206-85 | Sandoz | 9 May 2005 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 0781-3206-95 | Sandoz | 9 May 2005 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 50090-1875-0 | A-S Medication Solutions | 16 June 2015 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 50090-2444-0 | A-S Medication Solutions | 8 August 2016 |
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 85766-208-01 | Sportpharm | 23 July 2026 |
| 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 85766-208-10 | Sportpharm | 23 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 December 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ceftriaxone
Clinical summary
Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of infections when caused by susceptible bacteria, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Ceftriaxone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CeftriaxoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CEFTRIAXONE AND DEXTROSE prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Ceftriaxone 250 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.